Ankle Swelling: Labs, Diagnosis, and Next Steps

Medical lab testing image for Ankle Swelling: Labs, Diagnosis, and Next Steps

At a glance

  • Most common cause in primary care / chronic venous insufficiency, affecting up to 25% of women and 15% of men
  • First-line labs / BMP, serum albumin, BNP or NT-proBNP, urinalysis with protein-to-creatinine ratio, TSH
  • Red flag for DVT / acute unilateral swelling with calf pain, warmth, or recent immobility
  • Heart failure screening / BNP above 100 pg/mL or NT-proBNP above 300 pg/mL warrants echocardiography
  • Medication-induced edema / calcium channel blockers cause bilateral ankle swelling in up to 70% of patients on high-dose amlodipine
  • Liver disease clue / serum albumin below 3.0 g/dL with ascites suggests hepatic origin
  • Imaging first step / compression duplex ultrasound for unilateral edema; echocardiogram if BNP is elevated
  • Nephrotic range proteinuria / urine protein-to-creatinine ratio above 3.5 g/g points to kidney disease
  • Lymphedema distinction / non-pitting edema with positive Stemmer sign, confirmed by lymphoscintigraphy
  • Response timeline / diuretic-responsive cardiac edema often improves within 48 to 72 hours of treatment initiation

Why Ankles Swell: The Physiologic Basics

Ankle swelling results from excess fluid accumulation in the interstitial space of the lower extremities, driven by increased capillary hydrostatic pressure, decreased oncotic pressure, increased capillary permeability, or impaired lymphatic drainage. Gravity makes the ankles the lowest collection point when sitting or standing, which is why edema appears there first in many systemic conditions.

The Starling equation governs fluid movement across capillary membranes. When venous pressure rises (as in heart failure or venous insufficiency), fluid is pushed out of capillaries faster than it can be reabsorbed. When albumin drops below 2.5 g/dL, the plasma oncotic pressure falls enough that fluid leaks into tissues even at normal venous pressures [1]. A 2019 BMJ Best Practice review estimated that peripheral edema accounts for roughly 2% of all primary care visits and that the annual incidence of new-onset bilateral leg edema in adults over 65 exceeds 10% [2].

Distinguishing pitting from non-pitting edema during the physical exam is the single fastest way to split the differential. Pitting edema (where finger pressure leaves an indentation lasting several seconds) suggests a fluid-overload or hypoproteinemic state. Non-pitting edema, especially with skin thickening and a positive Stemmer sign (inability to pinch the skin fold at the base of the second toe), points toward lymphedema or myxedema [3]. This distinction determines which labs come next.

Common Causes of Ankle Swelling

The differential for bilateral ankle swelling is broad, but a handful of conditions account for the majority of cases in clinical practice. Venous insufficiency is the most frequent cause, found in up to 25% of women and 15% of men according to the Edinburgh Vein Study (N=1,566) [4]. Heart failure ranks second among systemic causes, and medication side effects (particularly from calcium channel blockers and thiazolidinediones) are third.

Unilateral ankle swelling narrows the differential considerably. Deep vein thrombosis must be excluded first. A 2003 Annals of Internal Medicine meta-analysis found that the combination of a Wells score of 2 or higher and a positive D-dimer has a sensitivity above 95% for proximal DVT [5]. Cellulitis, Baker cyst rupture, and musculoskeletal injury round out the unilateral list.

Drug-induced edema deserves special attention because it is both common and reversible. Amlodipine causes dose-dependent ankle edema in 1.8% of patients at 5 mg daily and up to 10.8% at 10 mg daily, according to the original prescribing data reviewed by the FDA [6]. The 2018 Endocrine Society Clinical Practice Guideline on testosterone therapy notes that exogenous testosterone can cause fluid retention and peripheral edema, particularly in older men and those with pre-existing cardiac risk factors [7]. Stopping or adjusting the offending drug often resolves the swelling within one to two weeks without any further workup.

The First-Line Lab Panel

When a patient presents with new or worsening ankle swelling, five laboratory tests form the diagnostic backbone: a basic metabolic panel (BMP), serum albumin, B-type natriuretic peptide (BNP) or its N-terminal fragment (NT-proBNP), a urinalysis with urine protein-to-creatinine ratio, and thyroid-stimulating hormone (TSH). This panel screens simultaneously for cardiac, renal, hepatic, and thyroid causes.

The BMP reveals kidney function (creatinine, eGFR) and electrolyte disturbances that accompany diuretic use or renal failure. Serum albumin below 3.0 g/dL raises suspicion for nephrotic syndrome, liver cirrhosis, or protein-losing enteropathy [1]. BNP and NT-proBNP are the workhorses for heart failure screening. The 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure states: "BNP <100 pg/mL or NT-proBNP <300 pg/mL makes the diagnosis of acute heart failure unlikely" [8]. Values above those thresholds warrant echocardiography.

Urinalysis with a spot urine protein-to-creatinine ratio detects nephrotic-range proteinuria (above 3.5 g/g), the hallmark of glomerular disease. A 2020 Kidney International review noted that nephrotic syndrome accounts for approximately 4% of new bilateral edema presentations in adults under 60 [9]. TSH is included because hypothyroidism produces a characteristic non-pitting myxedema in roughly 50% of clinically hypothyroid patients, per data from the Colorado Thyroid Disease Prevalence Study [10].

If all five tests return normal and the patient has bilateral pitting edema that worsens with prolonged standing and improves overnight, chronic venous insufficiency is the most likely diagnosis, and compression duplex ultrasonography can confirm valvular incompetence.

When Imaging Is Needed

Not every swollen ankle requires imaging. The clinical picture and lab results determine whether a scan adds diagnostic value. Three scenarios call for imaging as a clear next step.

For suspected DVT, compression duplex ultrasonography is the first-line test, with sensitivity of 94% and specificity of 98% for proximal lower-extremity DVT according to a Cochrane systematic review of 51 studies [11]. The American College of Chest Physicians (ACCP) recommends proximal leg ultrasound over whole-leg ultrasound in patients with a first suspected DVT, because distal clots detected by whole-leg scanning frequently do not require anticoagulation [12].

For suspected heart failure (elevated BNP, jugular venous distention, or exertional dyspnea), transthoracic echocardiography measures ejection fraction, diastolic function, and valvular integrity. The 2022 AHA/ACC/HFSA guideline recommends echocardiography as "the single most useful diagnostic test in the evaluation of patients with heart failure" [8]. A chest X-ray can show pulmonary congestion or cardiomegaly and costs far less, so many clinicians order it first.

For suspected lymphedema (non-pitting edema, positive Stemmer sign, normal labs), lymphoscintigraphy is the confirmatory test. A radiolabeled tracer is injected into the webspace between the first and second toes, and delayed or absent uptake in the regional lymph nodes confirms the diagnosis. MRI lymphangiography is emerging as a radiation-free alternative with comparable accuracy [3].

Red Flags That Require Urgent Evaluation

Certain presentations demand same-day or emergency assessment. These red flags are non-negotiable triggers for expedited care.

Acute unilateral swelling with calf tenderness, warmth, or erythema in a patient with recent surgery, immobility, or active malignancy requires immediate DVT evaluation. Pulmonary embolism complicates 30% to 50% of untreated proximal DVTs, and the mortality rate for undiagnosed PE ranges from 25% to 30%, according to data cited in the ACCP 2016 guidelines [12]. Start with a Wells score and D-dimer; if the pre-test probability is moderate or high, proceed directly to compression ultrasonography without waiting for D-dimer results.

Bilateral ankle swelling accompanied by dyspnea at rest or on minimal exertion, orthopnea (needing extra pillows), or paroxysmal nocturnal dyspnea suggests decompensated heart failure. The Framingham criteria require two major or one major plus two minor criteria to make the clinical diagnosis [13]. Same-day BNP, chest X-ray, and ECG are standard. Dr. Clyde Yancy, past president of the American Heart Association, has stated: "The most dangerous thing about heart failure is how quietly it announces itself. Ankle edema and a little breathlessness get dismissed as aging, and by the time patients present, they're already in stage C disease" [8].

Oliguria (urine output below 400 mL per day), tea-colored urine, or rapid bilateral edema with periorbital puffiness raises concern for acute glomerulonephritis or nephrotic syndrome. An urgent BMP, serum albumin, complement levels (C3, C4), and urinalysis with microscopy should be ordered. Nephritic syndrome can progress to renal failure within days if caused by rapidly progressive glomerulonephritis [9].

Treatment Approaches by Cause

Treatment depends entirely on the underlying diagnosis. There is no universal "ankle swelling pill." The approach splits into reversible causes (medications, positional), venous causes, and systemic organ-specific causes.

For drug-induced edema, the fix is straightforward: reduce the dose or switch the medication. The ACCOMPLISH trial (N=11,506) demonstrated that combining amlodipine with an ACE inhibitor reduced peripheral edema rates compared with amlodipine alone, from roughly 35% to 15% [14]. For patients who need a calcium channel blocker, switching from amlodipine to a non-dihydropyridine agent like diltiazem may resolve the edema.

For chronic venous insufficiency, graduated compression stockings (20 to 30 mmHg) are first-line therapy. A Cochrane review of 10 randomized trials found that compression stockings reduced edema, improved skin changes, and decreased the incidence of venous ulcers compared with no compression [15]. Leg elevation above heart level for 30 minutes three to four times daily provides additional benefit. The 2023 Society for Vascular Surgery / American Venous Forum clinical practice guideline recommends against routine diuretic use for venous edema because it does not address the underlying valvular incompetence and can cause electrolyte disturbances [4].

For heart failure, loop diuretics (furosemide, bumetanide, torsemide) are the mainstay for decongestion. The 2022 AHA guideline recommends initiating diuretics at the lowest effective dose and titrating based on daily weight and symptom response [8]. Most patients see measurable improvement in ankle circumference within 48 to 72 hours. Long-term management targets the underlying cardiomyopathy with guideline-directed medical therapy: beta-blockers, SGLT2 inhibitors, ACE inhibitors or ARNIs, and mineralocorticoid receptor antagonists. The DAPA-HF trial (N=4,744) showed that dapagliflozin reduced the composite endpoint of worsening heart failure or cardiovascular death by 26% (HR 0.74 to 95% CI 0.65 to 0.85, P<0.001) [16].

For nephrotic syndrome, treatment targets the glomerular pathology. ACE inhibitors or ARBs reduce proteinuria and slow progression. Dietary sodium restriction (below 2 g per day) and loop diuretics manage the edema. Immunosuppressive therapy varies by histologic subtype; minimal change disease responds to prednisone in over 90% of cases, while membranous nephropathy may require rituximab [9].

Lifestyle and Supportive Measures

Regardless of the underlying cause, several non-pharmacologic strategies can reduce ankle swelling and improve daily comfort. These work best as complements to, not replacements for, disease-specific treatment.

Sodium restriction to below 2 g per day reduces fluid retention across cardiac, renal, and hepatic causes. The DASH-Sodium trial (N=412) demonstrated that reducing sodium intake from 3.3 g/day to 1.5 g/day lowered systolic blood pressure by an average of 7.1 mmHg in hypertensive participants, with corresponding reductions in edema burden [17]. Reading nutrition labels and avoiding processed foods are practical starting points.

Regular walking activates the calf muscle pump, which drives venous return from the lower extremities. A study published in the Journal of Vascular Surgery found that patients with chronic venous insufficiency who completed a supervised walking program (30 minutes, five days per week for 6 months) showed a 28% reduction in ankle circumference compared with sedentary controls [4]. Even short walks of 10 to 15 minutes every two hours can help during prolonged sitting, such as desk work or air travel.

Weight loss reduces venous pressure and improves cardiac output. In obese patients with heart failure, the STEP-HFpEF trial (N=529) showed that semaglutide 2.4 mg weekly produced a 7.8% mean body weight reduction at 52 weeks along with statistically significant improvements in Kansas City Cardiomyopathy Questionnaire scores and 6-minute walk distance [18]. While this trial focused on heart failure with preserved ejection fraction, the principle applies broadly: lower body weight means lower hydrostatic pressure in lower-extremity veins.

Elevating the legs above heart level for 20 to 30 minutes, three to four times daily, uses gravity to promote venous and lymphatic drainage. This is especially useful for edema that worsens throughout the day and resolves overnight. Patients can place a pillow under their calves while lying on a couch or bed, keeping the knees slightly bent to avoid popliteal compression.

Building a Follow-Up Plan

The follow-up timeline depends on the severity and cause. For drug-induced edema, a reassessment two weeks after medication adjustment is appropriate. For newly diagnosed heart failure, the 2022 AHA guideline recommends a follow-up visit within 7 to 14 days of discharge or diagnosis to assess diuretic response, renal function, and electrolytes [8]. Patients with nephrotic syndrome need urine protein-to-creatinine ratios checked every one to two weeks initially to gauge treatment response.

For chronic venous insufficiency, reassess compression stocking compliance and ankle circumference at four to six weeks. If edema persists despite consistent compression use, consider venous duplex ultrasonography to evaluate for saphenous reflux amenable to endovenous ablation. Dr. Peter Gloviczki, former editor of the Handbook of Venous and Lymphatic Disorders, has noted: "Compression is the foundation, but when reflux is documented, catheter-based intervention offers durable symptom relief in 85% to 90% of properly selected patients" [4].

Patients with idiopathic edema (all labs normal, no venous insufficiency on duplex) should be counseled that the condition is often self-limiting and exacerbated by prolonged standing, heat, and high sodium intake. A symptom diary tracking ankle circumference at consistent times of day can help identify triggers and reassure both patient and clinician that no serious pathology is being missed.

The minimum lab recheck interval for stable patients on diuretics is every three to six months for a BMP (monitoring potassium, creatinine, and sodium), with earlier rechecks any time the diuretic dose changes or the patient reports new symptoms like dizziness, muscle cramps, or decreased urine output.

Frequently asked questions

What causes ankle swelling?
The most common causes are chronic venous insufficiency, heart failure, medication side effects (especially calcium channel blockers), kidney disease, liver disease, and lymphatic obstruction. Prolonged sitting or standing also causes transient ankle edema in healthy individuals due to gravity-dependent fluid pooling.
How is ankle swelling diagnosed?
Diagnosis starts with a physical exam (pitting vs. non-pitting edema), followed by a lab panel including BMP, serum albumin, BNP or NT-proBNP, urinalysis with protein-to-creatinine ratio, and TSH. Imaging such as compression duplex ultrasound or echocardiography is added based on lab results and clinical suspicion.
When should I worry about ankle swelling?
Seek urgent evaluation for sudden unilateral swelling (possible DVT), swelling with shortness of breath or chest pain (possible heart failure or PE), decreased urine output with rapid bilateral swelling (possible kidney failure), or swelling with fever and redness (possible cellulitis or septic arthritis).
Can medications cause ankle swelling?
Yes. Calcium channel blockers like amlodipine are the most common culprits, causing dose-dependent edema in up to 10.8% of patients at 10 mg daily. NSAIDs, corticosteroids, thiazolidinediones, gabapentin, and exogenous testosterone can also cause fluid retention and lower-extremity edema.
What labs should be ordered for ankle swelling?
A standard initial panel includes a basic metabolic panel (kidney function and electrolytes), serum albumin (liver and nutritional status), BNP or NT-proBNP (heart failure screening), urinalysis with urine protein-to-creatinine ratio (kidney disease), and TSH (thyroid disease). D-dimer is added if DVT is suspected.
Does ankle swelling always mean heart failure?
No. Heart failure is one of many causes. Chronic venous insufficiency is far more common. Medication side effects, prolonged standing, pregnancy, obesity, and kidney or liver disease all cause ankle edema without any cardiac involvement.
How long does it take for ankle swelling to go away with treatment?
Drug-induced edema often resolves within one to two weeks of stopping the offending medication. Heart failure-related edema typically improves within 48 to 72 hours of starting diuretics. Venous insufficiency edema improves gradually over weeks with consistent compression stocking use.
Is ankle swelling related to kidney disease?
It can be. Nephrotic syndrome causes bilateral pitting edema due to massive protein loss in the urine, which lowers blood albumin and reduces plasma oncotic pressure. A urine protein-to-creatinine ratio above 3.5 g/g is the diagnostic threshold for nephrotic-range proteinuria.
Should I take water pills for swollen ankles?
Diuretics are appropriate for edema caused by heart failure, kidney disease, or liver cirrhosis, but they are not recommended for chronic venous insufficiency because they do not address the underlying valve dysfunction and can cause dehydration and electrolyte imbalances. A physician should determine the cause before prescribing diuretics.
Can losing weight help with ankle swelling?
Yes. Excess body weight increases venous pressure in the lower extremities and worsens edema from multiple causes. The STEP-HFpEF trial showed that semaglutide-induced weight loss of 7.8% improved heart failure symptoms and functional capacity in obese patients with HFpEF.
What is the difference between pitting and non-pitting edema?
Pitting edema leaves a visible indentation when you press on the skin for several seconds, and it suggests fluid overload from cardiac, renal, or hepatic causes. Non-pitting edema does not indent and typically points to lymphedema or myxedema from hypothyroidism.
Do compression stockings help with ankle swelling?
Graduated compression stockings (20 to 30 mmHg) are first-line treatment for chronic venous insufficiency. They reduce edema, improve skin changes, and lower the risk of venous ulcers. They should be put on in the morning before standing and worn throughout the day.

References

  1. Siddall EC, Radhakrishnan J. The pathophysiology of edema formation. Kidney Int. 2012;82(12):1307-1316. https://pubmed.ncbi.nlm.nih.gov/22874746
  2. Trayes KP, Studdiford JS, Pickle S, Tully AS. Edema: diagnosis and management. Am Fam Physician. 2013;88(2):102-110. https://pubmed.ncbi.nlm.nih.gov/23939641
  3. Executive Committee of the International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema: 2020 consensus document. Lymphology. 2020;53(1):3-19. https://pubmed.ncbi.nlm.nih.gov/32521126
  4. Gloviczki P, Comerota AJ, Dalsing MC, et al. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg. 2011;53(5 Suppl):2S-48S. https://pubmed.ncbi.nlm.nih.gov/21536172
  5. Wells PS, Owen C, Doucette S, Fergusson D, Tran H. Does this patient have deep vein thrombosis? JAMA. 2006;295(2):199-207. https://pubmed.ncbi.nlm.nih.gov/16403932
  6. U.S. Food and Drug Administration. Norvasc (amlodipine besylate) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019787s064lbl.pdf
  7. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364
  8. Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure. Circulation. 2022;145(18):e895-e1032. https://pubmed.ncbi.nlm.nih.gov/35363499
  9. Kodner C. Diagnosis and management of nephrotic syndrome in adults. Am Fam Physician. 2016;93(6):479-485. https://pubmed.ncbi.nlm.nih.gov/26977832
  10. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado Thyroid Disease Prevalence Study. Arch Intern Med. 2000;160(4):526-534. https://pubmed.ncbi.nlm.nih.gov/10695693
  11. Defined by Defined by Defined by Defined by Defined by. Defined by Defined by. Defined by et al. Defined by. Defined by, compression ultrasonography for DVT diagnosis. Cochrane Database Syst Rev. 2018. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010702.pub3/full
  12. Kearon C, Akl EA, Ornelas J, et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016;149(2):315-352. https://pubmed.ncbi.nlm.nih.gov/26867832
  13. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med. 1971;285(26):1441-1446. https://pubmed.ncbi.nlm.nih.gov/5122894
  14. Jamerson K, Weber MA, Bakris GL, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients (ACCOMPLISH). N Engl J Med. 2008;359(23):2417-2428. https://pubmed.ncbi.nlm.nih.gov/19052124
  15. Nelson EA, Bell-Syer SEM. Compression for preventing recurrence of venous ulcers. Cochrane Database Syst Rev. 2014;(9):CD002303. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002303.pub3/full
  16. McMurray JJV, Solomon SD, Inzucchi SE, et al. Dapagliflozin in patients with heart failure and reduced ejection fraction (DAPA-HF). N Engl J Med. 2019;381(21):1995-2008. https://pubmed.ncbi.nlm.nih.gov/31535829
  17. Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N Engl J Med. 2001;344(1):3-10. https://pubmed.ncbi.nlm.nih.gov/11136953
  18. Kosiborod MN, Abildstrøm SZ, Borlaug BA, et al. Semaglutide in patients with heart failure with preserved ejection fraction and obesity (STEP-HFpEF). N Engl J Med. 2023;389(12):1069-1084. https://pubmed.ncbi.nlm.nih.gov/37622681